105 related articles for article (PubMed ID: 15624758)
41. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
42. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
43. Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.
Deckert M; Engert A; Brück W; Ferreri AJ; Finke J; Illerhaus G; Klapper W; Korfel A; Küppers R; Maarouf M; Montesinos-Rongen M; Paulus W; Schlegel U; Lassmann H; Wiestler OD; Siebert R; DeAngelis LM
Leukemia; 2011 Dec; 25(12):1797-807. PubMed ID: 21818113
[TBL] [Abstract][Full Text] [Related]
44. DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance.
Squatrito M; Holland EC
Cancer Res; 2011 Sep; 71(18):5945-9. PubMed ID: 21917735
[TBL] [Abstract][Full Text] [Related]
45. c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study.
Fritz P; Cabrera CM; Dippon J; Gerteis A; Simon W; Aulitzky WE; van der Kuip H
Breast Cancer Res; 2005; 7(3):R374-84. PubMed ID: 15987433
[TBL] [Abstract][Full Text] [Related]
46. Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patients.
Szybka M; Bartkowiak J; Zakrzewski K; Polis L; Liberski P; Kordek R
Clin Neuropathol; 2003; 22(4):180-6. PubMed ID: 12908754
[TBL] [Abstract][Full Text] [Related]
47. Pediatric neuro-oncology: current status and future directions.
Heath JA; Zacharoulis S; Kieran MW
Asia Pac J Clin Oncol; 2012 Sep; 8(3):223-31. PubMed ID: 22897924
[TBL] [Abstract][Full Text] [Related]
48. [Genes implicated in glial tumors].
Sanson M; Marie Y; Huguet S; He J; Hoang-Xuan K
Morphologie; 2000 Jun; 84(265):51-5. PubMed ID: 11048299
[TBL] [Abstract][Full Text] [Related]
49. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
50. Molecular pathogenesis of oligodendroglial tumors.
Jeuken JW; von Deimling A; Wesseling P
J Neurooncol; 2004 Nov; 70(2):161-81. PubMed ID: 15674476
[TBL] [Abstract][Full Text] [Related]
51. Molecular alterations in ependymomas.
Biernat W; Zawrocki A
Folia Neuropathol; 2007; 45(4):155-63. PubMed ID: 18176888
[TBL] [Abstract][Full Text] [Related]
52. Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.
Sefrioui D; Vermeulin T; Blanchard F; Chapusot C; Beaussire L; Armengol-Debeir L; Sesboué R; Gangloff A; Hebbar M; Copin MC; Houivet E; Schwarz L; Clatot F; Tuech JJ; Bénichou J; Martin L; Bouvier AM; Sabourin JC; Sarafan-Vasseur N; Frébourg T; Lepage C; Michel P; Di Fiore F
Int J Cancer; 2017 Apr; 140(7):1653-1661. PubMed ID: 28006840
[TBL] [Abstract][Full Text] [Related]
53. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
54. Expression of epidermal growth factor receptor and HER-2 in pediatric embryonal brain tumors.
Patereli A; Alexiou GA; Stefanaki K; Moschovi M; Doussis-Anagnostopoulou I; Prodromou N; Karentzou O
Pediatr Neurosurg; 2010; 46(3):188-92. PubMed ID: 20962551
[TBL] [Abstract][Full Text] [Related]
55. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
56. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
57. Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas.
Tabori U; Rienstein S; Dromi Y; Leider-Trejo L; Constantini S; Burstein Y; Dvir R; Amariglio N; Toren A; Rechavi G; Izraeli S; Aviram A
J Neurosurg; 2005 Oct; 103(4 Suppl):357-61. PubMed ID: 16270688
[TBL] [Abstract][Full Text] [Related]
58. The importance of genomic copy number changes in the prognosis of glioblastoma multiforme.
Arslantas A; Artan S; Oner U; Müslümanoğlu H; Durmaz R; Cosan E; Atasoy MA; Başaran N; Tel E
Neurosurg Rev; 2004 Jan; 27(1):58-64. PubMed ID: 12845540
[TBL] [Abstract][Full Text] [Related]
59. Shared molecular targets in pediatric gliomas and ependymomas.
Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
[TBL] [Abstract][Full Text] [Related]
60. [Role of genetic markers in the diagnosis and prognosis of tumors in children].
Delattre O
Arch Pediatr; 2001 May; 8 Suppl 2():362s-365s. PubMed ID: 11394118
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
